null (NOG) 
Previously established techniques of introducing additional genetic changes into transgenic or knockout mice include transgenic methods involving the direct microinjection of fertilized eggs and congenic strategies using extant genetically modified mice. The congenic strategy is the classical method and is easiest to perform, but, backcrossing must be performed for at least seven generations to replace over 99% of the genetic background (99.2% is theoretically replaced), which is extremely time-consuming. One of the fastest ways to introduce additional genetic modification is the markerassisted selection protocol (MASP) known as the "speed congenic" method. In MASP, the male mouse showing the most complete replacement with the targeted genetic background is selected as the "best" male and is used in the next backcross [11] [12] [13] . NOG (formally, NOD.Cg-Prkdc scid Il2rg tm1Sug /ShiJic) mice, which were developed by introducing IL2Rg null mutation from C57BL/6-Il2rg tm1Sug mice with backcross mating to NOD/Shi-scid mice [3] , have no lymphocytes (neither T nor B) or natural killer (NK) cells, and have impaired dendritic cell function [4, 7] . Therefore, NOG mice can be used to develop "humanized mice", which possess high levels of human-derived cells or tissues. Because it is difficult to label human cells (e.g. hematopoietic stem cells or neural stem cells) with visible markers, we -Note-attempted to introduce the enhanced green fluorescent protein (eGFP) gene into the NOG mouse as a visible recipient marker, which if successful would make it easier to differentiate donor cells from recipient cells in studies of transplantation and regenerative medicine. This study was performed in accordance with institutional guidelines and was approved by the Animal experimentation Committee of the Central Institute for experimental Animals. NOG mice expressing the eGFP gene can be obtained reliably by backcrossing with an animal in which the phenotype of the modified gene is already expressed in the donor. Therefore, we mated an inbred line of C57BL/6-Tg(Act-EGFP)C14-Y01-FM1310sb (C57BL/6-TgeGFP) mice [6, 8] Tg(Act-EGFP)C14-Y01-FM1310sb/ShiJic) mice. Tail clips of the mice were obtained and digested with proteinase K using standard methods [9] . Genomic DNA was extracted using the Magextractor System MFX-9600 Magnia R Plus (Toyobo, Osaka, Japan) according to the manufacturer's instructions. The eGFP transgene was genotyped by PCR with the forward primer GFP-F1 (5'-CTGGTCGAGCTGGACGGCGACG-3') and reverse primer GFP-R1 (5'-CACGAACTCCAGCAG-GACCATG-3'). The scid and IL2Rg null mutations were genotyped using a previously described PCR method [2, 3] . Three to six microsatellite markers were selected from each chromosome, including the X-chromosome. We selected 87 microsatellite markers to evaluate the mouse genetic backgrounds of the C57BL/6, NOG, and 129S6/Svev strains because the Tg eGFP mice originated in C57BL/6, and the IL2Rg null mutants were generated with mouse eS cells (CCe) derived from the 129S6/Svev strain. To evaluate the genetic background in more detail, an additional 17 microsatellite markers were arranged on chromosome 9. General information about the primers, including the size of the PCR product, is listed in To introduce the eGFP transgene into NOG mice, the first generation hybrid (F 1 ) was obtained by mating a male C57BL/6-TgeGFP mouse as the donor with a recipient NOG female mouse. The F 1 hybrid received a uniform genome (except for the sex chromosome) from the donor and recipient, and the replacement rate (described as "% Recipient genome" in Table 2 ) for both the expected and observed values was 50% (Table 2 ). In the next stage, a randomly selected male F 1 mouse with the eGFP transgene was again mated with female NOG recipient mice to obtain the N 2 generation. Marker-assisted selection was started at the N 2 generation to select the "best" male congenic mouse. using the 61 informative markers, the male with the closest NOG strain type was selected as the parent for the N 3 generation. using this method, the selection of males with the closest NOG strain type was repeated four times. The observed "% Recipient genome" of the male closest to the NOG background was 81.1, 95.9, 98.4, and 99.2% in the N 2 , N 3 , N 4 , and N 5 generations, respectively. The higher values of the observed "% Recipient genome" in generation N 3 and N 4 were statistically significant (P=0.018 and 0.067, respectively, Fisher's exact probability test). Wakeland et al. described the rationale of speed congenics, and stated that the advantage of screening with low-density markers (25 cM marker spacing) was realized in the N 3 and N 4 generations [12] . Com- puter simulations of MASP-based congenic strain construction strategies using high-density (10 cM apart) and low-density (25 cM apart) marker spacing, and screening a mean of 40 and 16 progeny per generation revealed that screening 16 progeny per generation with a lowdensity marker was the most cost-effective strategy. Our MASP strategy is similar to the computer-simulated most cost-effective strategy because 61 informative microsatellite markers were arranged throughout the mouse genome spaced at an average distance of 26.5 cM (low density), and we screened 13, 15, and 31 progeny at N 2 , N 3 , and N 4 , respectively. However, our MASP strategy included some gaps of over 30 cM, with a largest gap of 51.7 cM. One major problem is that a larger gap might not be able to detect a double crossing-over occurring in meiosis. Hameister et al. examined the frequency of double crossing-over in a 55.4-cM region between chromosome 15A2 and 15F2-3 in 151 mice and found only one animal with a double crossing-over [2] . In reality, double crossing-over does not occur at a high frequency, even in a larger gap extending over 50 cM. Therefore, detecting double crossing-over using adjacent markers might be possible. Another problem is the inability to detect a small segment of the donor genome. Because screening all gaps over 30 cM is unrealistic, we screened one large gap (43 cM) extending between D9Mit97 and D9Mit52 in more detail. We used extremely high-density markers (2.4 cM marker spacing) consisting of 17 informative markers in 12 and 14 progeny at N 2 and N 3 , respectively. No animal with a double crossing-over was found in 12 animals in the N 2 generation, while a small contaminating segment of the donor genome was detected between markers D9Mit207 and D9Mit107 in progeny #e109 of the N 3 generation (Fig. 1) . Considering an undetected contaminating donor genome, Wakeland et al. recommended performing one or two additional backcrosses when all of the markers become recipient-derived. This additional backcross reduces the level of undetected contamination in these strains to the equivalent of that at N 10 or N 11 using the traditional protocol [12] . When transferring a transgene or modified gene into the NOG or C57BL/6 strain from C57BL/6 or NOG and 129S6/Svev backgrounds, our selected 61 markers serve as genetic quality standards for generating a congenic strain using MASP. The final backcross could be completed because the NOG-eGFP mouse (N 5 ) met the genetic quality standards after backcrossing four times. However, we persisted with backcrossing during the production of congenic progeny derived from the N 5 generation for xenotransplantation studies. This additional backcross might confer some benefit through the further elimination of residual donor genomes.
To examine the phenotype of the NOG-eGFP mice, the male mouse closest to the NOG strain with eGFP transgene in the N 5 generation was mated with female NOG mice to obtain many NOG-eGFP mice (N 6 ) for xenotransplantation studies. NOD/Shi-scid mice (male, 10 weeks old), NOG mice (female, 7 weeks old), and NOG-eGFP mice (female, 12 weeks old) were irradiated with 2.4 Gy of X-rays 24 h before transplanting 5 a The generation count begins at strain P (parental) defined as 100% original background, 0% recipient background. The F 1 generation contains the offspring from the intercross between P (100% original) × pure recipient NOG strains (100% recipient). F 1 animals have 50% of the recipient genome. b The numbers of transgenic male mice whose genetic backgrounds were examined.
c R: the number of homozygotes for the allele of the recipient strain; total: total number of alleles. *P=0.015 and **P=0.095 (Fisher's exact probability test).
× 10 4 human CD34 + cells (Lonza Walkersville, Inc.).
The engraftment of donor cells was monitored every 4 weeks by detecting the human cells expressing the leukocyte common Ag CD45 (Immunotech, Marseille, France) using a MoFlo flow cytometer (Dako, Glostrup, Denmark) and Summit software. Representative flow cytometric analysis of peripheral blood of mice that underwent transplantation (after 12 weeks) is shown in Fig.  2a . When using NOG-eGFP mice as recipients, we could easily differentiate donor human cells from recipient mouse cells with the fluorescent signals of the eGFP, although the cells were not stained with any cell surface marker for the mouse species. Twelve weeks after transplantation, significantly more growth of human cells was observed in both NOG mice and NOG-eGFP mice compared to NOD/Shi-scid mice (*P<0.01; **P<0.001; Fig. 2b ), but there was no significant difference between NOG mice and NOG-eGFP mice. These results suggest that the NOG-eGFP mice, which were generated by the congenic method with MASP, acquired the immunological properties of the NOG strain.
In this experiment, we did not use X-chromosomederived microsatellite markers as informative markers to select a parent for the next generation because the X-chromosome is always derived from the recipient NOG strain in male transgenic mice. However, we checked the X-chromosome with informative markers to distinguish between the NOG and 129S6/Svev strains (the source of the CCe eS cells) because of the confirmation of an X-chromosome linked IL2Rg null mutation (Chr X, 38 cM) derived from the recipient genome. However, the nearest marker located at 32.1 cM was not informative, and the other three markers on the X-chromosome were shown to be homozygous for recipientderived alleles. Nakanishi et al. analyzed transgene integration sites in more than 100 EGFP transgenic mouse lines rigorously using fluorescent in situ hybridization and determined that the eGFP transgene is located on the D1 region of chromosome 14 in the 131 line (C57BL/6-Tg (Act-EGFP) C14-Y01-FM1310sb) [6] . The microsatellite markers that did not become NOG markers in the N 4 generation were the markers D14Mit233 and D14Mit225, both of which are on chromosome 14. Fortunately, we could change the genetic background around the D14Mit225 region from C57BL/6 to the NOG strain in the N 5 generation, but the genetic background around the D14Mit233 region remained C57BL/6. D14Mit233 The screening is depicted schematically using genotyping data in which each box indicates one informative microsatellite marker primer pair. The yellow boxes represent those PCR products that are identified as NOG homozygotes based on size. The red boxes represent C57BL/6 and NOG heterozygotes. The asterisks indicate the "best" males that were selected as the parents of the next backcross generation.
and D14Mit225 are located in the B and D1-D3 regions, respectively. These markers are located extremely close to the site of EGFP transgene integration in the C5BL/6-TgeGFP line 131. The D14Mit233 marker seemed to be closer to the integrated transgene than the D14Mit225 marker because six recombinants at the D14Mit225 locus were observed in the 63 male Tg eGFP mice, while no recombinant was observed for the D14Mit233 marker. The distance from the D14Mit225 marker to the integrated eGFP transgene can be calculated as roughly 9.5 cM based on the recombination frequency [10] . Based on statistical modeling, the traditional 12 backcross generation (N 12 ) protocol will produce a congenic strain in which more than 99% of the genome is unlinked to the target gene carried in a donor-derived genome segment with an average length of about 20 cM [1] . Therefore, the D14Mit233 marker genetically linked to the transgene integration site is physically close enough to the transgene that it will not segregate independently during meiosis.
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